AAAAAA
Results:
1-16
|
Results: 16
Authors:
HERRSTEDT J
AAPRO MS
SMYTH JF
DELFAVERO A
Citation: J. Herrstedt et al., CORTICOSTEROIDS, DOPAMINE ANTAGONISTS AND OTHER DRUGS, Supportive care in cancer, 6(3), 1998, pp. 204-214
Authors:
HERRSTEDT J
Citation: J. Herrstedt, ANTIEMETIC RESEARCH - A LOOK TO THE FUTURE, Supportive care in cancer, 6(1), 1998, pp. 8-12
Authors:
HANDBERG J
WESSEL V
LARSEN L
HERRSTEDT J
HANSEN HH
Citation: J. Handberg et al., RANDOMIZED, DOUBLE-BLIND COMPARISON OF GRANISETRON VERSUS GRANISETRONPLUS PREDNISOLONE AS ANTIEMETIC PROPHYLAXIS DURING MULTIPLE-DAY CISPLATIN-BASED CHEMOTHERAPY, Supportive care in cancer, 6(1), 1998, pp. 63-67
Authors:
ROILA F
DELFAVERO A
GRALLA RJ
TONATO M
AAPRO MS
ANDREWS PLR
BALLATORI E
DEMULDER PHM
DICATO MA
DUBOIS A
FEYER PC
GANDARA DR
GRALLA RJ
GRALLA RJ
GROSHEN S
GRUNBERG SM
HERRSTEDT J
HESKETH PJ
JOSS RA
KRIS MG
MARTY MM
MORROW GR
NAYLOR RJ
OLVER IN
SMYTH JF
SPITZER TR
STEWART A
Citation: F. Roila et al., PREVENTION OF CHEMOTHERAPY-INDUCED AND RADIOTHERAPY-INDUCED EMESIS - RESULTS OF THE PERUGIA CONSENSUS CONFERENCE, Annals of oncology, 9(8), 1998, pp. 811-819
Authors:
SIGSGAARD T
HERRSTEDT J
HANDBERG J
KJAER M
DOMBERNOWSKY P
Citation: T. Sigsgaard et al., RANDOMIZED, DOUBLE-BLIND, PARALLEL TRIAL OF THE ANTIEMETIC EFFICACY AND SAFETY OF ONDANSETRON (OND) PLUS METOPIMAZINE (MPZ) VERSUS OND PLUSMPZ PLUS PREDNISOLONE (PRED) DURING MULTIPLE CYCLES OF MODERATELY EMETOGENIC CHEMOTHERAPY (CT), Annals of oncology, 9, 1998, pp. 675-675
Authors:
HERRSTEDT J
Citation: J. Herrstedt, CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING WITH SPECIAL EMPHASIS ON METOPIMAZINE, Danish medical bulletin, 45(4), 1998, pp. 412-422
Authors:
BALLATORI E
ROILA F
DEANGELIS V
CICCARESE G
PALLADINO MA
TONATO M
DELFAVERO A
HERRSTEDT J
DICATO M
DUBOIS A
HESKETH P
KRIS M
GRALLA RJ
Citation: E. Ballatori et al., CLINICAL AND METHODOLOGICAL ISSUES IN ANTIEMETIC THERAPY - A WORLDWIDE SURVEY OF EXPERTS OPINIONS, Supportive care in cancer, 5(4), 1997, pp. 269-273
Authors:
HERRSTEDT J
SIGAGAARD T
ANGELO HR
KAMPMANN JP
HANSEN M
Citation: J. Herrstedt et al., DOSE-FINDING STUDY OF ORAL METOPIMAZINE, Supportive care in cancer, 5(1), 1997, pp. 38-43
Authors:
HERRSTEDT J
SIGSGAARD T
HANDBERG J
SCHOUSBOE BMB
HANSEN M
DOMBERNOWSKY P
Citation: J. Herrstedt et al., RANDOMIZED, DOUBLE-BLIND COMPARISON OF ONDANSETRON VERSUS ONDANSETRONPLUS METOPIMAZINE AS ANTIEMETIC PROPHYLAXIS DURING PLATINUM-BASED CHEMOTHERAPY IN PATIENTS WITH CANCER, Journal of clinical oncology, 15(4), 1997, pp. 1690-1696
Authors:
HERRSTEDT J
Citation: J. Herrstedt, NEW PERSPECTIVES IN ANTIEMETIC TREATMENT, Supportive care in cancer, 4(6), 1996, pp. 416-419
Authors:
HERRSTEDT J
Citation: J. Herrstedt, DEVELOPMENT OF ANTIEMETIC THERAPY IN CANCER-PATIENTS, Acta oncologica, 34(5), 1995, pp. 637-640
Authors:
HERRSTEDT J
Citation: J. Herrstedt, WE STILL NEED COMMON CRITERIA FOR THE ASSESSMENT OF NAUSEA AND VOMITING, European journal of cancer, 30A(9), 1994, pp. 1217-1217
Authors:
SVENSTRUP B
HERRSTEDT J
BRUNNER N
BENNETT P
WACHMANN H
DOMBERNOWSKY P
Citation: B. Svenstrup et al., SEX-HORMONE LEVELS IN POSTMENOPAUSAL WOMEN WITH ADVANCED METASTATIC BREAST-CANCER TREATED WITH CGS-169-49A, European journal of cancer, 30A(9), 1994, pp. 1254-1258
Authors:
HERRSTEDT J
HYTTEL J
PEDERSEN J
Citation: J. Herrstedt et al., INTERACTION OF THE ANTIEMETIC METOPIMAZINE AND ANTICANCER AGENTS WITHBRAIN DOPAMINE D(2), 5-HYDROXYTRYPTAMINE(3), HISTAMINE H-1, MUSCARINECHOLINERGIC AND ALPHA(1)-ADRENERGIC RECEPTORS, Cancer chemotherapy and pharmacology, 33(1), 1993, pp. 53-56
Authors:
STENBYGAARD LE
HERRSTEDT J
THOMSEN JF
SVENDSEN KR
ENGELHOLM SA
DOMBERNOWSKY P
Citation: Le. Stenbygaard et al., TOREMIFENE AND TAMOXIFEN IN ADVANCED BREAST-CANCER - A DOUBLE-BLIND CROSS-OVER TRIAL, Breast cancer research and treatment, 25(1), 1993, pp. 57-63
Authors:
HERRSTEDT J
SIGSGAARD T
DOMBERNOWSKY P
Citation: J. Herrstedt et al., ANTIEMETIC EFFECTS OF ONDANSETRON AND METOPIMAZINE - REPLY, The New England journal of medicine, 329(18), 1993, pp. 1356-1357
Risultati:
1-16
|